human serum albumin

By Targets:	Biochemical Assay Reagents (1) Fluorescent Dye (2) Interleukin Related (2) NF-κB (1) NO Synthase (1) Ser/Thr Protease (1) TNF Receptor (1)
By Research Areas:	Cancer (2) Cardiovascular Disease (2) Inflammation/Immunology (4) Metabolic Disease (1)

Targets Recommended: SGK

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-P1956

**Human serum albumin** 1 Publications Verification HSA	NF-κB NO Synthase	Cardiovascular Disease Inflammation/Immunology
Human serum albumin (HSA) is the most abundant protein in plasma and is a major determinant of plasma oncotic pressure. Human serum albumin exhibits antioxidant, anticoagulant, anti-inflammatory, anti-platelet aggregation activities as well as colloid osmotic action. Human serum albumin can block the inhibitory effect of GML on human T cells, providing protective function for T cells. Human serum albumin is also associated with cardiovascular diseases and can partially prevent the LPS (HY-D1056) induced oxidative stress, as well as the upregulation of NF-κB, NF-κB, and peroxynitrite (ONOO ⁻) in the vascular wall, contributing to the reduction of blood pressure .

HY-150097

*Recombinant Human* Serum Albumin(rHSA)**	Biochemical Assay Reagents	Others
Recombinant Human Serum Albumin (rHSA) is an active compound and possesses an identical conformation to plasma derived HSA. Recombinant Human Serum Albumin (rHSA) has no difference between rHSA and plasma derived HSA. Recombinant Human Serum Albumin (rHSA) has high efficacy of rHSA with little or no adverse reaction .

HY-P99397

Sonelokimab ALX 0761; M 1095	Interleukin Related	Inflammation/Immunology
Sonelokimab (ALX 0761; M 1095) is a trivalent nanobody comprised of monovalent camelid-derived nanobodies specific to human interleukin (IL)-17A, IL-17F, and human serum albumin VHHs. Sonelokimab has the potential for plaque-type psoriasis research .

HY-P99696

Lerodalcibep LIB003	Ser/Thr Protease	Cardiovascular Disease Metabolic Disease
Lerodalcibep (LIB003) is a recombinant fusion protein of a PCSK9-binding domain (adnectin) and human serum albumin. Lerodalcibep is a Lipid-lowering agent. Lerodalcibep can be used for the research of hypercholesterolemia and cardiovascular diseases .

HY-150978

DDAO-C6	Fluorescent Dye	Others
DDAO-C6 is a cridone ester derivative, highly specific fluorescence for detecting human serum albumin (HSA). DDAO-C6 acts as an enzymatic activatable near-infrared fluorescent probe in visually sensing endogenous lipase from gut microbes (Ex/Em=600/658 nm) .

HY-139248

Paclitaxel octadecanedioate	Others	Cancer
Paclitaxel octadecanedioate (compound PTX-FA18) is comprised of Paclitaxel (HY-B0015) conjugated to 1,18-octadecanedioic acid (HY-W005178). Paclitaxel octadecanedioate mixed with human serum albumin (HAS) is cytotoxic to HT-1080, PANC-1, HT-29 and Hela cells (IC₅₀s = 12, 2.48, 8.62, and 64.42 nM, respectively) .

HY-D0022

5-Aminofluorescein 5-AF	Fluorescent Dye	Others
5-Aminofluorescein (5-AF) is a fluorescence marker, covalently bound to human serum albumin. The excitation wavelength is 495 nm and the emission wavelength is 535 nm .

HY-N12329

Fumonisin B4

Others Others

Fumonisin B4 is a derivative of fumonisin. Fumonisin B4 has low albumin binding capacity .

Fumonisin B4	Others	Others
Fumonisin B4 is a derivative of fumonisin. Fumonisin B4 has low albumin binding capacity .

HY-P99796

Ozoralizumab ATN-103	TNF Receptor	Inflammation/Immunology
Ozoralizumab (ATN-103) is an anti-TNFα humanized antibody. Ozoralizumab is a humanized trivalent nanobody compound that consists of two anti-human TNFα nanobodies and an anti-human serum albumin (HSA) nanobody. Ozoralizumab can be used in research of arthritis .

HY-P99385

Vobarilizumab ALX-0061	Interleukin Related	Inflammation/Immunology
Vobarilizumab (ALX-0061) is an anti-IL-6R monoclonal antibody (mAb) (K_d: 0.19 pM). Vobarilizumab consists of an anti-IL-6R domain and an anti-human serum albumin domain. Vobarilizumab can be used in the research of inflammatory autoimmune diseases, such as rheumatoid arthritis .

HY-N2252

Licarin A (+)-Licarin A
Licarin A ((+)-Licarin A), a neolignan, significantly and dose-dependently reduces TNF-α production (IC₅₀=12.6 μM) in dinitrophenyl-human serum albumin (DNP-HSA)-stimulated RBL-2H3 cells. Anti-allergic effects. Licarin A reduces TNF-α and PGD2 production, and COX-2 expression .

Cat. No.	Product Name	Type

HY-D0022

5-Aminofluorescein 5-AF	Fluorescent Dyes/Probes
5-Aminofluorescein (5-AF) is a fluorescence marker, covalently bound to human serum albumin. The excitation wavelength is 495 nm and the emission wavelength is 535 nm .

HY-150978

DDAO-C6	Fluorescent Dyes/Probes
DDAO-C6 is a cridone ester derivative, highly specific fluorescence for detecting human serum albumin (HSA). DDAO-C6 acts as an enzymatic activatable near-infrared fluorescent probe in visually sensing endogenous lipase from gut microbes (Ex/Em=600/658 nm) .

Cat. No.	Product Name	Type

HY-P1956

**Human serum albumin** 1 Publications Verification HSA	Native Proteins
Human serum albumin (HSA) is the most abundant protein in plasma and is a major determinant of plasma oncotic pressure. Human serum albumin exhibits antioxidant, anticoagulant, anti-inflammatory, anti-platelet aggregation activities as well as colloid osmotic action. Human serum albumin can block the inhibitory effect of GML on human T cells, providing protective function for T cells. Human serum albumin is also associated with cardiovascular diseases and can partially prevent the LPS (HY-D1056) induced oxidative stress, as well as the upregulation of NF-κB, NF-κB, and peroxynitrite (ONOO ⁻) in the vascular wall, contributing to the reduction of blood pressure .

Human serum albumin

1 Publications Verification

HSA

Native Proteins

Human serum albumin (HSA) is the most abundant protein in plasma and is a major determinant of plasma oncotic pressure. Human serum albumin exhibits antioxidant, anticoagulant, anti-inflammatory, anti-platelet aggregation activities as well as colloid osmotic action. Human serum albumin can block the inhibitory effect of GML on human T cells, providing protective function for T cells. Human serum albumin is also associated with cardiovascular diseases and can partially prevent the LPS (HY-D1056) induced oxidative stress, as well as the upregulation of NF-κB, NF-κB, and peroxynitrite (ONOO ⁻) in the vascular wall, contributing to the reduction of blood pressure .

HY-150097

*Recombinant Human* Serum Albumin(rHSA)**	Biochemical Assay Reagents
Recombinant Human Serum Albumin (rHSA) is an active compound and possesses an identical conformation to plasma derived HSA. Recombinant Human Serum Albumin (rHSA) has no difference between rHSA and plasma derived HSA. Recombinant Human Serum Albumin (rHSA) has high efficacy of rHSA with little or no adverse reaction .

Cat. No.	Product Name	Target	Research Area

HY-P99397

Sonelokimab ALX 0761; M 1095	Interleukin Related	Inflammation/Immunology
Sonelokimab (ALX 0761; M 1095) is a trivalent nanobody comprised of monovalent camelid-derived nanobodies specific to human interleukin (IL)-17A, IL-17F, and human serum albumin VHHs. Sonelokimab has the potential for plaque-type psoriasis research .

HY-P99796

Ozoralizumab ATN-103	TNF Receptor	Inflammation/Immunology
Ozoralizumab (ATN-103) is an anti-TNFα humanized antibody. Ozoralizumab is a humanized trivalent nanobody compound that consists of two anti-human TNFα nanobodies and an anti-human serum albumin (HSA) nanobody. Ozoralizumab can be used in research of arthritis .

HY-P99696

Lerodalcibep LIB003	Ser/Thr Protease	Cardiovascular Disease Metabolic Disease
Lerodalcibep (LIB003) is a recombinant fusion protein of a PCSK9-binding domain (adnectin) and human serum albumin. Lerodalcibep is a Lipid-lowering agent. Lerodalcibep can be used for the research of hypercholesterolemia and cardiovascular diseases .

HY-P99845

Dazodalibep

MEDI 4920; VIB 4920
Inhibitory Antibodies Others

Dazodalibep (MEDI 4920; VIB 4920) is a monoclonal antibody targeting CD40LG/TNFSF5 fused to human serum albumin ALB/HSA .

Dazodalibep MEDI 4920; VIB 4920	Inhibitory Antibodies	Others
Dazodalibep (MEDI 4920; VIB 4920) is a monoclonal antibody targeting CD40LG/TNFSF5 fused to human serum albumin ALB/HSA .

HY-P99458

Balugrastim CG 10639	Inhibitory Antibodies	Cancer
Balugrastim (CG 10639) is a novel long-acting recombinant granulocyte colony-stimulating factor (G-CSF) obtained by means of a genetic fusion between recombinant human serum albumin and granulocyte colony-stimulating factor. Balugrastim can be used for the research of breast cancer .

HY-P99385

Vobarilizumab ALX-0061	Interleukin Related	Inflammation/Immunology
Vobarilizumab (ALX-0061) is an anti-IL-6R monoclonal antibody (mAb) (K_d: 0.19 pM). Vobarilizumab consists of an anti-IL-6R domain and an anti-human serum albumin domain. Vobarilizumab can be used in the research of inflammatory autoimmune diseases, such as rheumatoid arthritis .

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-N12329

Fumonisin B4	Structural Classification Microorganisms Ketones, Aldehydes, Acids Source classification	Others
Fumonisin B4 is a derivative of fumonisin. Fumonisin B4 has low albumin binding capacity .

Species:	Human (3)
Tag:	His (2) Tag Free (1) Avi (2)
Source:	HEK293 (2) P. pastoris (1)

Cat. No.	Compare	Product Name	Species	Source

HY-P7875

	Serum Albumin/ALB Protein, Human (P.pastoris) rHuserum albumin; serum albumin; HSA; ALB	Human	P. pastoris
	The serum albumin/ALB protein has multiple binding abilities and can bind water, Ca(2+), Na(+), K(+), fatty acids, hormones, bilirubin, and drugs. Its main effects include regulating blood colloid osmotic pressure to achieve homeostasis. Serum Albumin/ALB Protein, Human (P.pastoris) is the recombinant human-derived Serum Albumin/ALB protein, expressed by P. pastoris , with tag free. The total length of Serum Albumin/ALB Protein, Human (P.pastoris) is 585 a.a., with molecular weight of 55-80 kDa.

HY-P78393

	Serum Albumin/ALB Protein, Human (HEK293, His-Avi) albumin; ALB; serum albumin; ANALBA; FDAH; PRO0883; PRO0903; PRO1341	Human	HEK293
	Serum Albumin/ALB Protein has versatile binding capabilities, binding water, Ca(2+), Na(+), K(+), fatty acids, hormones, bilirubin, and drugs. Its primary role involves regulating blood colloidal osmotic pressure for homeostasis. ALB acts as a major transporter for zinc, binding 80% of plasma zinc, and 45% of circulating calcium and magnesium. It interacts with the bacterial siderophore enterobactin, inhibiting E. coli's iron uptake. ALB also engages with FCGRT, regulating homeostasis, and forms a covalently-linked complex with chromophore-bound alpha-1-microglobulin, highlighting diverse molecular interactions and maintaining functionality in fatty acid binding. Serum Albumin/ALB Protein, Human (HEK293, His-Avi) is the recombinant human-derived Serum Albumin/ALB protein, expressed by HEK293, with C-Avi, C-His labeled tag. The total length of Serum Albumin/ALB Protein, Human (HEK293, His-Avi) is 585 a.a., with molecular weight of 69-70 kDa.

HY-P78077

	Serum Albumin/ALB Protein, Human (Biotinylated, HEK293, His-Avi) albumin; ALB; serum albumin; ANALBA; FDAH; PRO0883; PRO0903; PRO1341	Human	HEK293
	Serum Albumin/ALB Protein has versatile binding capabilities, binding water, Ca(2+), Na(+), K(+), fatty acids, hormones, bilirubin, and drugs. Its primary role involves regulating blood colloidal osmotic pressure for homeostasis. ALB acts as a major transporter for zinc, binding 80% of plasma zinc, and 45% of circulating calcium and magnesium. It interacts with the bacterial siderophore enterobactin, inhibiting E. coli's iron uptake. ALB also engages with FCGRT, regulating homeostasis, and forms a covalently-linked complex with chromophore-bound alpha-1-microglobulin, highlighting diverse molecular interactions and maintaining functionality in fatty acid binding. Serum Albumin/ALB Protein, Human (Biotinylated, HEK293, His-Avi) is the recombinant human-derived Serum Albumin/ALB protein, expressed by HEK293, with C-Avi, C-His labeled tag. The total length of Serum Albumin/ALB Protein, Human (Biotinylated, HEK293, His-Avi) is 585 a.a., with molecular weight of 69-70 kDa.


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Product Name	Application	Reactivity

HY-P81281

Human Serum Albumin Antibody (YA984) ALB; ALBU_human; albumin (32 AA); albumin (AA 34); albumin; Analbuminemia; Bisalbuminemia; Cell growth inhibiting protein 42; DKFZp779N1935; Dysalbuminemic hyperthyroxinemia; Growth inhibiting protein 20; HSA; Hyperthyroxinemia dysalbuminemic; serum albumin.	LFIA, ELISA	Human

HY-P81281A

Human Serum Albumin Antibody (YA985) ALB; ALBU_human; albumin (32 AA); albumin (AA 34); albumin; Analbuminemia; Bisalbuminemia; Cell growth inhibiting protein 42; DKFZp779N1935; Dysalbuminemic hyperthyroxinemia; Growth inhibiting protein 20; HSA; Hyperthyroxinemia dysalbuminemic; serum albumin.	WB, ELISA	Human

HY-P81281B

Human Serum Albumin Antibody (YA986) ALB; ALBU_human; albumin (32 AA); albumin (AA 34); albumin; Analbuminemia; Bisalbuminemia; Cell growth inhibiting protein 42; DKFZp779N1935; Dysalbuminemic hyperthyroxinemia; Growth inhibiting protein 20; HSA; Hyperthyroxinemia dysalbuminemic; serum albumin.	WB, ELISA	Human

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inhibitors & Agonists

Fluorescent Dye

Biochemical Assay Reagents

Inhibitory Antibodies

Natural
Products

Recombinant Proteins

Antibodies